Presentation is loading. Please wait.

Presentation is loading. Please wait.

Kaplan-Meier plots of the duration of continuous albuterol, time until q4 albuterol, and hospital LOS for each of the 4 treatment groups. Kaplan-Meier.

Published byNeuza Lima Modified over 5 years ago

Similar presentations

Presentation on theme: "Kaplan-Meier plots of the duration of continuous albuterol, time until q4 albuterol, and hospital LOS for each of the 4 treatment groups. Kaplan-Meier."— Presentation transcript:

1 Kaplan-Meier plots of the duration of continuous albuterol, time until q4 albuterol, and hospital LOS for each of the 4 treatment groups. Kaplan-Meier plots of the duration of continuous albuterol, time until q4 albuterol, and hospital LOS for each of the 4 treatment groups. A, Duration of continuous albuterol. B, Time until q4 albuterol. C, Hospital LOS. Shorter “survival” times represent shorter durations of treatment. Steven L. Shein et al. Hospital Pediatrics 2018;8:89-95 ©2018 by American Academy of Pediatrics

Download ppt "Kaplan-Meier plots of the duration of continuous albuterol, time until q4 albuterol, and hospital LOS for each of the 4 treatment groups. Kaplan-Meier."

Similar presentations

Copyright © 2017 American Academy of Pediatrics.

Copyright © 2017 American Academy of Pediatrics.
 Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

 Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.
Nighttime parent experience.

Nighttime parent experience.
Persistence of first tumour necrosis factor alpha inhibitor (TNFi) by TNFi Kaplan-Meier plot of time (years) to discontinuation of treatment by TNFi. (A)

Persistence of first tumour necrosis factor alpha inhibitor (TNFi) by TNFi Kaplan-Meier plot of time (years) to discontinuation of treatment by TNFi. (A)
Percentage of nursing assessments with NEWS documented for patients 21 years and older from March to October 2015. Percentage of nursing assessments with.

Percentage of nursing assessments with NEWS documented for patients 21 years and older from March to October Percentage of nursing assessments with.
Variation in Metrics from the SHM-CWC pediatric recommendations from 32 children’s hospitals in the United States from 2013 Q1 to 2015 Q3. Variation in.

Variation in Metrics from the SHM-CWC pediatric recommendations from 32 children’s hospitals in the United States from 2013 Q1 to 2015 Q3. Variation in.
Variation in Metrics from the SHM-CWC pediatric recommendations from 32 children’s hospitals in the United States from 2013 Q1 to 2015 Q3. Variation in.

Variation in Metrics from the SHM-CWC pediatric recommendations from 32 children’s hospitals in the United States from 2013 Q1 to 2015 Q3. Variation in.
Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.
Fertility and Sterility  Volume 98, Issue 5, Pages (November 2012)

Fertility and Sterility  Volume 98, Issue 5, Pages (November 2012)
Association between hospital-level diagnostic testing and 3-day ED return visits at 34 US children’s hospitals. Association between hospital-level diagnostic.

Association between hospital-level diagnostic testing and 3-day ED return visits at 34 US children’s hospitals. Association between hospital-level diagnostic.
Kaplan-Meier survival curve demonstrating treatment duration of metformin and orlistat. Kaplan-Meier survival curve demonstrating treatment duration of.

Kaplan-Meier survival curve demonstrating treatment duration of metformin and orlistat. Kaplan-Meier survival curve demonstrating treatment duration of.
Hospital-level procedural sedation rates among pediatric patients in the earliest year, (2009, red circle) and the most recent year (2014, blue bar). Hospital-level.

Hospital-level procedural sedation rates among pediatric patients in the earliest year, (2009, red circle) and the most recent year (2014, blue bar). Hospital-level.
Interhospital variation in pharmacologic treatment of neonates with NAS and NICU admission among pharmacologically-treated neonates with NAS from 2013.

Interhospital variation in pharmacologic treatment of neonates with NAS and NICU admission among pharmacologically-treated neonates with NAS from 2013.
Kaplan-Meier plot of incident CVD according to the treatment group over a 4-year period following intensification of diabetes therapy. Kaplan-Meier plot.

Kaplan-Meier plot of incident CVD according to the treatment group over a 4-year period following intensification of diabetes therapy. Kaplan-Meier plot.
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
Catherine M. Pound et al. Hospital Pediatrics 2017;7:

Catherine M. Pound et al. Hospital Pediatrics 2017;7:
Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.

Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.
A, Comparison of cortisol levels between the nonintervention group (n = 94) and the intervention group (n = 104). A, Comparison of cortisol levels between.

A, Comparison of cortisol levels between the nonintervention group (n = 94) and the intervention group (n = 104). A, Comparison of cortisol levels between.
Kaplan-Meier plots of hHF: DPP-4i and SU cohort with baseline CVD (panel A); saxagliptin and sitagliptin cohorts with baseline CVD (panel B); DPP-4i and.

Kaplan-Meier plots of hHF: DPP-4i and SU cohort with baseline CVD (panel A); saxagliptin and sitagliptin cohorts with baseline CVD (panel B); DPP-4i and.
Kaplan-Meier survival curves for the development of diabetes by quartiles of baseline pedometer steps. Kaplan-Meier survival curves for the development.

Kaplan-Meier survival curves for the development of diabetes by quartiles of baseline pedometer steps. Kaplan-Meier survival curves for the development.

Similar presentations

Ads by Google